4Antithrombotic Trialists' Collaboration. Collaborative Meta- analysis of randomised trials of antiplate|et therapy for pre- vention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002,324 : 71-86.
3Sacco RL, Adams R, Albers G, et al; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37: 577-617.
4Sappok T, Faulstich A, Stuckert E, et al. Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke, 2001, 32: 1884- 1889.
5Ellul J, Talelli P, Papapetropoulos T. Are neurologists more likely to prescribe antithrombotic therapy after stroke? Stroke, 2004, 35:2241 - 2242.
6Lago A, Tembl JI, Pareja A, et al; Stroke Project (Cerebrovascular Diseases Group of the Spanish Neurological Society). Adherence to aspirin in secondary prevention of ischemic stroke. Cerebrovasc Dis, 2006, 21:353 - 356.
7De Schryver EL, van Gijn J, Kappelle LJ, et al; Dutch TIA trial and SPIRIT study groups. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol, 2005, 252: 1316- 1321.
8Hamann GF, Weimar C, Glahn J, et al; German Stroke Data Bank. Adherence to secondary stroke prevention strategies-results from the German Stroke Data Bank. Cerebrovasc Dis, 2003, 15:282 -288.
9Chukwuma CS,Tuomilento J.Diabetes and the risk of stroke(J)[].Journal of Diabetes and Its Complications.1993
10Lehto S,Ronnemaa T,Pyorala K,et al.Predictors of stroke in middle-aged patients with non- insulin- dependent diabetes[].Stroke.2003
